BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 36526699)

  • 1. Simultaneous analysis of tumor-infiltrating immune cells density, tumor budding status, and presence of lymphoid follicles in CRC tissue.
    Markowski AR; Markowska AJ; Ustymowicz W; Pryczynicz A; Guzińska-Ustymowicz K
    Sci Rep; 2022 Dec; 12(1):21732. PubMed ID: 36526699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E-Cadherin Expression Varies Depending on the Location within the Primary Tumor and Is Higher in Colorectal Cancer with Lymphoid Follicles.
    Markowski AR; Ustymowicz K; Markowska AJ; Romańczyk W; Guzińska-Ustymowicz K
    Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer.
    Schweiger T; Berghoff AS; Glogner C; Glueck O; Rajky O; Traxler D; Birner P; Preusser M; Klepetko W; Hoetzenecker K
    Clin Exp Metastasis; 2016 Oct; 33(7):727-39. PubMed ID: 27449756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumoral infiltrating lymphocytes correlate with improved survival in colorectal cancer patients: Independent of oncogenetic features.
    Nazemalhosseini-Mojarad E; Mohammadpour S; Torshizi Esafahani A; Gharib E; Larki P; Moradi A; Amin Porhoseingholi M; Asadzade Aghdaei H; Kuppen PJK; Zali MR
    J Cell Physiol; 2019 Apr; 234(4):4768-4777. PubMed ID: 30370522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer.
    Kuwahara T; Hazama S; Suzuki N; Yoshida S; Tomochika S; Nakagami Y; Matsui H; Shindo Y; Kanekiyo S; Tokumitsu Y; Iida M; Tsunedomi R; Takeda S; Yoshino S; Okayama N; Suehiro Y; Yamasaki T; Fujita T; Kawakami Y; Ueno T; Nagano H
    Br J Cancer; 2019 Oct; 121(8):659-665. PubMed ID: 31488881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact of heterogeneously distributed tumor-infiltrating lymphocytes on the prognosis of colorectal cancer.
    Liu L; Long M; Su S; Wang L; Liu J
    PeerJ; 2024; 12():e16747. PubMed ID: 38223758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High tissue expression of TLRs combined with high density of tumor infiltrating lymphocytes predicts a better prognosis in colorectal cancer patients.
    Beilmann-Lehtonen I; Kasurinen J; Hagström J; Kaprio T; Böckelman C; Haglund C
    PLoS One; 2023; 18(1):e0280085. PubMed ID: 36649244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour budding/T cell infiltrates in colorectal cancer: proposal of a novel combined score.
    Dawson H; Christe L; Eichmann M; Reinhard S; Zlobec I; Blank A; Lugli A
    Histopathology; 2020 Mar; 76(4):572-580. PubMed ID: 31560788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-associated CD3- and CD8-positive immune cells in colorectal cancer: The additional prognostic value of CD8+-to-CD3+ ratio remains debatable.
    Kasurinen J; Hagström J; Kaprio T; Beilmann-Lehtonen I; Haglund C; Böckelman C
    Tumour Biol; 2022; 44(1):37-52. PubMed ID: 35404299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of CD4+ and CD8+ tumor-infiltrating lymphocytes in patients with colorectal cancer.
    Tao Y; Xie Y
    Acta Chir Belg; 2024 Feb; 124(1):35-40. PubMed ID: 36780176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential gene expression of tumor-infiltrating CD8
    Saleh R; Sasidharan Nair V; Toor SM; Taha RZ; Murshed K; Al-Dhaheri M; Khawar M; Petkar MA; Abu Nada M; Al-Ejeh F; Elkord E
    J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32948653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-infiltrating lymphocyte: features and prognosis of lymphocytes infiltration on colorectal cancer.
    Qin M; Chen G; Hou J; Wang L; Wang Q; Wang L; Jiang D; Hu Y; Xie B; Chen J; Wei H; Xu G
    Bioengineered; 2022 Jun; 13(6):14872-14888. PubMed ID: 36633318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between primary colorectal cancer histology and the histopathological growth patterns of corresponding liver metastases.
    Höppener DJ; Stook JPL; Galjart B; Nierop PMH; Nagtegaal ID; Vermeulen PB; Grünhagen DJ; Verhoef C; Doukas M;
    BMC Cancer; 2022 Aug; 22(1):911. PubMed ID: 35996090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Budding and tumor-infiltrating lymphocytes - combination of both parameters predicts survival in colorectal cancer and leads to new prognostic subgroups.
    Lang-Schwarz C; Melcher B; Haumaier F; Lang-Schwarz K; Rupprecht T; Vieth M; Sterlacci W
    Hum Pathol; 2018 Sep; 79():160-167. PubMed ID: 29787819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immune-Related Factors as Prognostic Markers for Resectable Colorectal Cancer].
    Tomochika S; Kuwahara T; Suzuki N; Hazama S; Nagano H
    Gan To Kagaku Ryoho; 2021 Mar; 48(3):325-330. PubMed ID: 33790150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of tumor budding in colorectal adenocarcinoma: Possible involvement of the intestinal cancer stem cell marker Lgr5.
    Sadek SA; A Rehim DM; Fatima S
    Indian J Pathol Microbiol; 2020; 63(1):32-37. PubMed ID: 32031119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CMTM6 and PD-L1 coexpression is associated with an active immune microenvironment and a favorable prognosis in colorectal cancer.
    Peng QH; Wang CH; Chen HM; Zhang RX; Pan ZZ; Lu ZH; Wang GY; Yue X; Huang W; Liu RY
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33579737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour budding, poorly differentiated clusters, and T-cell response in colorectal cancer.
    Fujiyoshi K; Väyrynen JP; Borowsky J; Papke DJ; Arima K; Haruki K; Kishikawa J; Akimoto N; Ugai T; Lau MC; Gu S; Shi S; Zhao M; Da Silva AFL; Twombly TS; Nan H; Meyerhardt JA; Song M; Zhang X; Wu K; Chan AT; Fuchs CS; Lennerz JK; Giannakis M; Nowak JA; Ogino S
    EBioMedicine; 2020 Jul; 57():102860. PubMed ID: 32652320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Prognostic Significance of the Tumor-infiltrating Programmed Cell Death-1
    Shibutani M; Maeda K; Nagahara H; Fukuoka T; Nakao S; Matsutani S; Hirakawa K; Ohira M
    Anticancer Res; 2017 Aug; 37(8):4165-4172. PubMed ID: 28739701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors.
    Zlobec I; Lugli A
    World J Gastroenterol; 2009 Dec; 15(47):5898-906. PubMed ID: 20014453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.